莫沙必利及妈咪爱防治早产儿喂养不耐受的疗效评价
The efficacy of mosapride and Medilac-Vita in treating preterm neonates with feeding intolerance
-
摘要: 目的:研究莫沙必利及妈咪爱防治早产儿胃肠喂养不耐受疗效。方法:2004~2005年住院早产儿107例(未给药组),未给予莫沙必利及妈咪爱预防早产儿喂养不耐受;2006~2008年住院早产儿260例(给药组),入院后即给予莫沙必利及妈咪爱预防早产儿喂养不耐受。观察2组早产儿喂养不耐受发生率及喂养不耐受患儿恢复出生体重时间及达到全胃肠道喂养时间。结果:给药组、未给药组发生喂养不耐受分别为65例、38例,发病率分别为24.07%、35.51%;喂养不耐受患儿恢复出生体重时间分别为(11.173.87)d、(12.923.91)d,达到全胃肠道喂养时间分别为(9.053.26)d、(11.766.28)d;2组差异均有统计学意义(P0.01)。结论:莫沙必利及妈咪爱可有效防治早产儿喂养不耐受。
-
关键词:
- 婴儿,早产,疾病,喂养不耐受 /
- 莫沙必利 /
- 妈咪爱
Abstract: Objective:To observe the efficacy of mosapride and Medilac-Vita in treating preterm neonates with feeding intolerance.Methods:One hundred and seven preterm neonates in hospital from Jan.2004 to Dec.2005 were treated as control group.The other 260 preterm neonates in hospital from Jan.2006 to Dec.2008 feeding with Mosapride and Medilac-Vitad to prevent feeding intolerance were regarded as treated group.The incidences of feeding intolerance in the two groups were observed.The time to reach ful1 enteral feeding and the time to reach the birth weight in the preterm neonates with feeding intolerance were recorded.Results:Sixty five preterm neonates emerged feeding intolerance in treated group,the incidence was 24.07%.In these 65 cases,the time to reach the birth weight was(11.173.87)d and the time to reach full enteral feeding was(9.053.26)d.Thirty-eight preterm neonates emerged feeding intolerance in control group,the incidence was 35.51%.In the 38 cases,the time to reach full enteral feeding was(11.766.28)d,the time to reach the birth weight was(12.923.91)d.Compared with the treated group,the difference was conspicuous.Conclusions:Mosapride and Medilac-Vita show definite effect in preventing and treating preterm neonates with feeding intolerance.-
Key words:
- preterm neonates /
- feed intolerance /
- mosapride
-
[2] 黄东明,杨华姿.微量喂养对早产儿胃泌素和胃动素水平的影响[J].新生儿科杂志,2007,17(4):145-146. [2] 黄瑛,邵肖梅,曾纪骅,等.新生儿喂养困难与红霉索促胃肠动力的研究[J].中华儿科杂志,2000,38(11):696-698. [3] 陈红武,瞿隽,姚英民.红霉素在喂养不耐受新生儿中应用[J].临床儿科杂志,2003,21(2):116-117. [4] Ng PC,Lee CH,Wong SP,et al.High-dose oral erythromycin decreased the incidence of parenteral nutrition-associated cholestasis in preterm infants[J].Gastroenterology,2007,132(5):1726-1739. [5] Ng E,Shah VS.Erythromycin for the prevention and treatment of feeding intolerance in preterm infants[J].Cochrane Database Syst Rev,2008,16(3):CD001815. [6] Chhina S,Peverini RL,Deminq DD,et al.QTC interval in infants receiving cisapvied[J].J Perinatol,2002,22(1):144-148. [7] 宋朝敏,吴斌.益生菌在早产新生儿临床应用研究进展[J].中华围产医学杂志,2006,9(3):208-209. [8] Lee SJ,Cho SJ,Park EA.Effects of probiotics on enteric flora and fee-ding tolerance in preterminfants[J].Neonatology,2007,91(3):174-179. [9] 贾霜,赵力波,孙淑娟,等.微生态制剂的作用机制及临床应用进展[J].中国药业,2006,15(12):59-60. [10] 贺湘英,李琪,梁琨,等.金双歧片治疗极低出生体质量儿喂养不耐受[J].实用儿科临床杂志,2007,22(2):138-139. [11] Rautava S.Potential uses of probiotics in the neonate[J].Semin Fetal Neonatal Med,2007,12(1):45-53. [12] Deshpande G,Rao S,Patole S.Probiotics for prevention of necrotisingenterocolitis in preterm neonateswith very low birthweight:a systematicreview of randomised controlled trials[J].Lancet,2007,369(9573):1614-1620. [13] Caffarelli C,Bernasconi S.Preventing necrotising enterocolitiswith pro-biotics[J].Lancet,2007,369(9573):1578-1580. [14] 陈艳娟,谢润华,余文霞,等.微生态制剂对早产儿喂养不耐受及早期生长发育的影响[J].实用儿科临床杂志,2007,23(14):1108-1109. -

计量
- 文章访问数: 2489
- HTML全文浏览量: 315
- PDF下载量: 106
- 被引次数: 0